A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04874350
- Locations
- ๐บ๐ธ
University of Maryland Medical Center, Baltimore, Maryland, United States
๐บ๐ธUniversity of Texas Southwestern, Dallas, Texas, United States
๐บ๐ธUniversity of California, Los Angeles, Los Angeles, California, United States
A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04685993
- Locations
- ๐บ๐ธ
Sun Research Institute, San Antonio, Texas, United States
๐บ๐ธSensible Healthcare, LLC, Ocoee, Florida, United States
๐บ๐ธClinical Trials Research, Roseville, California, United States
The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
- Conditions
- Interventions
- First Posted Date
- 2019-10-21
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT04134091
- Locations
- ๐บ๐ธ
R&H Clinical Research, Katy, Texas, United States
๐บ๐ธTriWest Research Associates, LLC, El Cajon, California, United States
๐บ๐ธUnited Medical Doctors, Murrieta, California, United States
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
- First Posted Date
- 2019-03-08
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 138
- Registration Number
- NCT03868059
- Locations
- ๐บ๐ธ
Neostart Corporation dba AGA Clinical Trials, Hialeah, Florida, United States
๐บ๐ธJacksonville Impotence Treatment Center, Jacksonville, Florida, United States
๐บ๐ธAventiv Research, Inc., Columbus, Ohio, United States
Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)
- First Posted Date
- 2017-08-08
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03242408
Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).
- First Posted Date
- 2017-08-08
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 95
- Registration Number
- NCT03242590
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
- Conditions
- Interventions
- First Posted Date
- 2014-03-07
- Last Posted Date
- 2017-10-23
- Lead Sponsor
- Lipocine Inc.
- Target Recruit Count
- 315
- Registration Number
- NCT02081300